MedPath

Nitto Biopharma, Inc.

Nitto Biopharma, Inc. logo
🇺🇸United States
Ownership
Private
Employees
51
Market Cap
-
Website
https://nittobiopharma.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer

Phase 1
Completed
Conditions
Non-Small Cell Lung Cancer
Pancreatic Cancer
Colorectal Cancer
Interventions
First Posted Date
2019-01-28
Last Posted Date
2024-07-24
Lead Sponsor
Nitto BioPharma, Inc.
Target Recruit Count
49
Registration Number
NCT03819387
Locations
🇺🇸

Beverly Hills Cancer Center, Beverly Hills, California, United States

🇺🇸

UC San Diego Moores Cancer Center, La Jolla, California, United States

🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

and more 6 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.